Profiling the impact of the promoters on CRISPR-Cas12a system in human cells

Cell Mol Biol Lett. 2023 May 17;28(1):41. doi: 10.1186/s11658-023-00454-9.

Abstract

The plasmid vector platform is the most commonly used vector for the expression of the versatile CRISPR-Cas technique and the promoter is a crucial element for the expression vector, thus profiling the impact of the promoters on CRISPR editors provides the basic information for the gene-editing toolkits and can be a guideline for its design. Herein, we made a parallel comparison among four commonly used promoters (CAG, ~ 1700 bp; EF1a core, ~ 210 bp; CMV, ~ 500 bp; and PGK, ~ 500 bp) in CRISPR-Cas12a system in mammalian cells to explore the impact of promoters on this powerful tool. We found that without badly damaging targeting specificity, the CAG promoter-driving Cas12a editor exhibited the most active (efficiency takes as 100%, specificity index = ~ 75%) in genomic cleavage, multiplex editing, transcriptional activation, and base editing, followed by promoter CMV (efficiency = 70 ~ 90% (vs CAG), specificity index = ~ 78%), and then EF1a core and PGK (both efficiency = 40-60%, vs CAG) but with higher specificity (specificity index = ~ 84% and ~ 82%, respectively). Therefore, CAG is recommended in the CRISPR-Cas12a system for the applications that need a robust editing activity but without size limitation, CMV mostly can be an alternative for CAG when requiring a smaller space, EF1a is similar to PGK with relatively high specificity, but has a smaller size, thus is more suitable for in vivo therapeutic applications. The data outlined the properties of the widely used promoters in the CRISPR-Cas12a system, which can be a guide for its applications and can be a useful resource for the gene-editing field.

Keywords: CRISPR-Cas system; Comparison; Impact; Plasmid design; Promoters.

Publication types

  • Letter

MeSH terms

  • Animals
  • CRISPR-Associated Proteins* / genetics
  • CRISPR-Associated Proteins* / metabolism
  • CRISPR-Cas Systems / genetics
  • Cytomegalovirus Infections* / genetics
  • Gene Editing / methods
  • Genetic Vectors
  • Humans
  • Mammals / genetics

Substances

  • CRISPR-Associated Proteins